Skip to content
MedsAcross

Medicine

Ondansetron 24 mg tablet

Ondansetron · Oral
Available on requestPrescription onlyUS FDAGeneric name

Ondansetron 24 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°-25°C (68°-77°F). Protect from light.

Key facts

Active ingredient (INN)
Ondansetron
Brand
Sold under the generic name
Strength
24 mg
Dosage form
Tablet
Route
Oral
Packs
1 blister pack, 500 tablets, 1 dose pack and 3 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaAurobindo PharmaIndiaAsclemed
Origin register
US FDA, United States
Storage
Store at 20°-25°C (68°-77°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A04AA01 Ondansetron
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 December 2006
Identifiers
RxCUI 198052, 312084, 312086DailyMed set ID 162f2088-9fb1-47e7-b88c-45104be7e7bb, 57578387-1918-4e56-a564-f14fb22340bf, 65b0b2e2-37fd-4d08-9674-954d62bb531aNDC 55111-156, 65862-189, 76420-917Application ANDA076183, ANDA078539

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack65862-189-11Aurobindo PharmaIndia31 July 2007
500 tablet, film coated in 1 bottle55111-156-05Dr. Reddy's LaboratoriesIndia26 December 2006
1 dose pack in 1 box / 1 tablet, film coated in 1 dose pack55111-156-11Dr. Reddy's LaboratoriesIndia26 December 2006
30 tablet, film coated in 1 bottle55111-156-30Dr. Reddy's LaboratoriesIndia26 December 2006
10 dose pack in 1 box / 10 tablet, film coated in 1 dose pack55111-156-78Dr. Reddy's LaboratoriesIndia26 December 2006
1 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack76420-917-01Asclemed28 January 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 4 January 1991Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Ondansetron

Clinical summary

Ondansetron is a serotonin-3 receptor antagonist. It is available as tablets, orally disintegrating tablets and injection for intramuscular and intravenous use. MedsAcross supplies Ondansetron for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ondansetron

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ondansetron 24 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.